The risk signature for cuproptosis in colon cancer patients includes ZEB1-AS1 and SNHG7 [35, 36], while ATP2A1-AS1 was incorporated into the lncRNA-based prognosis prediction model for cuproptosis in patients with cervical cancer [37]. This evidence concerns the gene ATP2A1 and malignant colon neoplasm.